A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. 1986

J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan

The combination cytosine arabinoside (ara-C), daunorubicin, and VP 16-213 was studied in 28 patients with acute non-lymphocytic leukemia to define the toxicity of the combination and assess its efficacy. Of 21 previously untreated patients, 16 (76%) achieved a complete response (CR) with the median remission duration not reached but exceeding 25 weeks. For CR patients, the median number of days with neutrophils less than 500/microliter was 19. The median survival for patients with CR is 60 weeks. Two of seven previously treated patients achieved CR for 11 weeks and in excess of 36 weeks, respectively. At the initial VP16-213 dose of 100 mg m-2 per day for seven days, severe stomatitis was seen in 38% of courses but was less with dose reduction to 75 mg m-2 per day for seven days. Other toxicity was similar to previous experience with ara-C and daunorubicin alone.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
January 1996, Haematologia,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
November 1977, Cancer treatment reports,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
September 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
April 1991, Blood,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
July 1999, International journal of hematology,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
October 1972, Ugeskrift for laeger,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
March 1989, Cancer,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
January 1979, Leukemia research,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
October 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
J F Bishop, and D E Joshua, and R M Lowenthal, and H Kronenberg, and M G Whiteside, and R Cobcroft, and A Dodds, and M Wolf, and A Manoharan
February 1984, European journal of cancer & clinical oncology,
Copied contents to your clipboard!